Cameroon vs Eritrea: Treatment success rate for patients treated for MDR-TB
Cameroon
82.0%
in 2022
Eritrea
81.0%
in 2022
Cameroon rank
44th
Eritrea rank
46th
Treatment success rate for patients treated for MDR-TB over time
- Cameroon
- Eritrea
How they compare
Cameroon currently reports 82.0% against 81.0% in Eritrea, a difference of 1.0%.
The two have swapped places 5 times across 12 shared years of data; in 2011 it was Eritrea ahead.
Cameroon ranks 44th and Eritrea ranks 46th of 163 countries.
Eritrea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cameroon | Eritrea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 76.9% | 81.4% | 4.6% | Eritrea |
| 2020s | 79.7% | 82.3% | 2.7% | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Cameroon or Eritrea?
- Cameroon, at 82.0% against 81.0% in Eritrea as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Cameroon and Eritrea?
- 1.0%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Eritrea?
- 12 years are reported by both, from 2011 to 2022.
- How do Cameroon and Eritrea rank globally for treatment success rate for patients treated for mdr-tb?
- Cameroon ranks 44th and Eritrea ranks 46th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.